CTSN Embolic Protection Trial (NCT06027788)

🧪 Interventions in This Study

• CardioGard Embolic Protection Cannula (DEVICE)
• Standard Aortic Cannula (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (28 Sites)

Showing the first 25 of 28 sites.

• CHI St. Vincent Heart Institute — North Little Rock, Arkansas
• Keck Hospital of the University of Southern California — Los Angeles, California
• Emory University — Atlanta, Georgia
• Indiana University — Bloomington, Indiana
• Indiana Ohio Heart — Fort Wayne, Indiana
• Ochsner Clinic — New Orleans, Louisiana
• Maine Medical Center — Portland, Maine
• Johns Hopkins Medicine — Baltimore, Maryland
• University of Maryland — College Park, Maryland
• Massachusetts General Hospital — Boston, Massachusetts
• University of Michigan — Ann Arbor, Michigan
• Mayo Clinic — Rochester, Minnesota
• Saint Luke's Hospital of Kansas City — Kansas City, Missouri
• Columbia University Medical Center — New York, New York
• New York Presbyterian-Cornell Medical Center — New York, New York
• NYU Langone Hospital Brooklyn — New York, New York
• Northwell Health — New York, New York
• Montefiore Medical Center — The Bronx, New York
• Duke University — Durham, North Carolina
• University Hospitals — Cleveland, Ohio
• Cleveland Clinic — Cleveland, Ohio
• Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
• University of Virginia — Charlottesville, Virginia
• West Virginia University — Morgantown, West Virginia
• London Health Sciences Centre — London, Ontario

📞 Contact the Study Coordinator

Phone: (917) 494-2387

Email: Claudia.merlin@mountsinai.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Delirium

• Digital Rehabilitation Environment Augmenting Medical System — Gainesville, Florida
• Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care — Houston, Texas
• Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors — Rockford, Illinois
• Intelligent Intensive Care Unit — Gainesville, Florida
• Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium — St Louis, Missouri
• Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery — Toronto, Ontario

Explore by condition: All Delirium clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.